Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2025-12-26 @ 11:00 AM
NCT ID:
NCT02620306
Eligibility Criteria:
Inclusion Criteria:
1. Male and female adults aged 19 years or older
2. Blood pressure: Mean blood pressure is as below at screening.
* For treatment-naïve patients: 140 mmHg ≤ SBP \< 180 mmHg and DBP \< 110 mmHg
* For patients who are taking ACEI or ARB: 130 mmHg ≤ SBP \< 180 mmHg and DBP \< 110 mmHg
3. eGFR: ≥ 30 ml/min/1.73 m2 within the past 6 months
4. Albuminuria (ACR) excretion volume: Meets one or more of the following conditions
* ACR \> 300 mg/g (or mg/day) within the past 12 months
* There are at least two results of 30 ≤ ACR ≤ 300 mg/g (or mg/day) within the past 12 months and the interval between the two test is at least 12 weeks.
5. Patients with diabetes
6. Voluntarily provided a written consent to participate
7. Able to understand this study, be cooperative in the execution of the study
Exclusion Criteria:
1. Severe hypertension with mean SBP ≥ 180 mmHg or DBP ≥ 110 mmHg
2. Orthostatic hypotension with symptoms
3. Insulin dependent diabetes mellitus or uncontrolled diabetes mellitus
4. Patients on dialysis, patients with clinically significant cardiac and hepatic diseases
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT02620306
Study Brief:
Protocol Section:
NCT02620306